The biochemical and biophysical properties of mucins are largely determined
by extensive O-glycosylation of serine- and threonine-rich tandem repeat (
TR) domains. In a number of human diseases aberrant O-glycosylation is asso
ciated with variations in the properties of the cell surface-associated and
secreted mucins, To evaluate in vivo the O-glycosylation of mucin TR domai
ns, we generated recombinant chimeric mucins with TR sequences from MUC2, M
UC4 MUC5AC, or MUC5B, which were substituted for the native TRs of epitope-
tagged MUC1 protein (MUC1F), These hybrid mucins were extensively O-glycosy
lated and showed the expected association with the cell surface and release
into culture media. The presence of different TR domains within the chimer
ic mucins appears to have limited influence on their posttranslational proc
essing. Alterations in glycosylation were detailed by fast atom bombardment
mass spectrometry and reactivity with antibodies against particular blood-
group and tumor-associated carbohydrate antigens, Future applications of th
ese chimeras will include investigations of mucin posttranslational modific
ation in the context of disease.